ProQR Therapeutics Gets BofA Buy Initiation After Positive AX-0810 Phase 1 Data
AX-0810 Phase 1 shows dose-dependent bile acid increases and no serious adverse events, delivering the first human proof of concept for ProQR’s Axiomer RNA editing.
AX-0810 Phase 1 shows dose-dependent bile acid increases and no serious adverse events, delivering the first human proof of concept for ProQR’s Axiomer RNA editing.
Cantor Fitzgerald initiates Overweight coverage on Milestone, citing Cardamyst’s strong PSVT launch potential and $250-300M peak sales outlook.
Advance Auto Parts reported Q2 same-store sales down 0.5% as DIY spending slowed. Adjusted EPS beat estimates; full-year sales guidance held steady.
Walmart’s U.S. comps grew just 2.6% in Q2 FY27, missing estimates, yet the retailer raised full-year sales and EPS targets on e-commerce strength.
President Trump hosted top crypto executives at the White House and urged Congress to pass a fair version of the Clarity Act for clearer industry rules.
Etsy stock rises in analysts’ eyes: BofA to Buy with $105 PT, Rosenblatt initiates at $95. Growth under new CEO looks more durable.